ArticleImmunotherapy advances2025

Implementing adjuvant immunotherapy following radical chemoradiotherapy for stage III non-small-cell lung cancer in UK clinical practice-Are the PACIFIC trial outcomes achievable in the real world?

Radwa Fawzy Ahmed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.